State Street’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

State Street’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,085	Closed	-$326K	–	4878
2022 Q4	$326K	Buy	16,085 +2,800	+21%	+$42.9K	﹤0.01%	3920
2022 Q3	$143K	Hold	13,285	–	–	﹤0.01%	4288
2022 Q2	$159K	Hold	13,285	–	–	﹤0.01%	4311
2022 Q1	$285K	Buy	13,285 +1,285	+11%	+$34K	﹤0.01%	4257
2021 Q4	$404K	Buy	+12,000	New	+$334K	﹤0.01%	4095

State Street's OPNT Position: Q1 2023 in Review

State Street sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 16,085 shares — an estimated $326K sold.

State Street first reported a position in OPNT in Q4 2021 and held it in 5 quarters. The position peaked at $404K in Q4 2021. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

State Street reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
State Street sold 16,085 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $326K.
State Street first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
State Street's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $404K in Q4 2021.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.